This announcement is a separate document:
丰原药业：独立董事2023年度述职报告（吴慈生）
Anhui Fengyuan Pharmaceutical: Independent Director's 2023 Debriefing Report (Wu Cisheng)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
10:08
ZEEKR 001: Cumulative deliveries have exceeded 250,000 units, maintaining the position of the best-selling pure electric vehicle in China above 250,000 units.
ZK+0.88%
10:03
Xiamen Hongxin Electronics Technology Group Inc.: Suihong Huachuang helps to achieve a compute power scale breakthrough of 0.05 million P in Qingyang.
Xiamen Hongxin Electronics Technology Group Inc.-0.41%
09:55
The adjustment amount for the nutrition program for rural students exceeds 4 billion yuan.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.